Lilly, AbbVie, BMS and more rally against UK's 'arbitrary' growth cap on branded drug market
17th October 2023 Uncategorised 0 Lilly, AbbVie, BMS and more rally against UK’s ‘arbitrary’ growth cap on branded drug market
fkansteiner
Tue, 10/17/2023 – 14:53
More: Lilly, AbbVie, BMS and more rally against UK's 'arbitrary' growth cap on branded drug market
Source: fierce